Mitochondrial transcription factor A (TFAM) (TFAM)

Mitochondrial transcription factor A (TFAM) is a nuclear-encoded protein essential for the maintenance, expression, and organization of the mitochondrial genome (mtDNA). Upon translocation into the mitochondria, TFAM binds to regulatory regions such as the displacement loop (D-loop), the light strand promoter (LSP), and the heavy strand promoters (HSP1/2) to initiate mtDNA transcription and replication (UniProt P40926; PubMed: 29272718). Beyond its role as a transcription factor, TFAM acts as a structural protein that coats and compacts mtDNA into nucleoids, protecting the genome from oxidative damage and regulating its availability for biological processes (PubMed: 31513936). Dysregulation of TFAM is associated with mitochondrial DNA depletion syndromes, neurodegenerative diseases like Alzheimer's and Parkinson's, and age-related metabolic decline (PubMed: 24509214). Pharmacological targeting of TFAM often involves indirect activation through the PGC-1alpha/NRF signaling pathway using agents like bezafibrate or resveratrol, or direct protein replacement therapy to restore mitochondrial function (PubMed: 18458140; PubMed: 21115511). However, therapeutic modulation must be carefully managed, as TFAM overexpression can support the high metabolic demands of certain cancer cells, potentially promoting tumor progression (PubMed: 28847001).

Other names

Transcription factor 6TCF6TCF-6MTFTmtTFATranscription factor 6-like 2

Upregulation of mitochondrial biogenesis via the PGC-1alpha/NRF/TFAM pathway and direct stabilization of the mitochondrial genome through nucleoid formation.